Expand Energy Corporation reports Q2 results on July 29 with options markets flashing their most defensive signal in months — and short sellers quietly rebuilding positions heading into the release.
The clearest tension into earnings is in options. The put/call ratio has climbed to 1.27, more than two standard deviations above its 20-day average of 0.91 — a level of downside hedging not seen since the ratio briefly spiked to its 52-week high of 2.01. That shift has been sharp and recent: as recently as July 16, the PCR sat near its 52-week floor at 0.72, meaning the swing toward puts has happened almost entirely within the past two weeks. The stock itself closed at $88.52 on July 28, down 2.2% on the day but essentially flat over the past week — a period when close peers EQT gained 6% and RRC added 3.3%, making EXE's flat tape look like relative underperformance rather than stability. Short interest has risen steadily too, climbing roughly 50% over the past month to 4% of the free float — still not extreme in absolute terms, but the direction of travel is unambiguous. Borrow availability remains very loose at nearly 1,925%, so the short build reflects bearish conviction rather than a technically forced move.
The debate heading into the print is genuinely split. Bulls point to a meaningful step-up in net asset value per share — from $13.50 to $20 — driven by improved EBITDA margins and well productivity running 40% above basin averages, alongside production growth of 15% year-over-year. The mean analyst price target of $124.24 implies roughly 40% upside from current levels, and the consensus remains constructive despite recent target cuts from UBS, Truist, and Citigroup in early July — all of which trimmed numbers while keeping Buy ratings intact, suggesting the Street sees a valuation cushion rather than a fundamental problem. Bears counter with a concrete set of concerns: an 11% year-over-year drop in well productivity by one measure, expected production softness into early 2026, and natural gas prices that remain hostage to pipeline capacity constraints. Barclays stepped off the bull side in late May, cutting to Equal-Weight at $110 — the only outright downgrade in the recent window — and that caution has only grown as the stock has drifted further below the consensus target.
One softer positive in the setup is insider behavior. The Chairman and the CFO both bought shares in early June at prices around $88–$93, right in the neighborhood of the current print. Those were modest purchases — totaling around $560,000 combined over 90 days — but the fact that both the board chair and the finance chief added at current levels adds a faint contrarian signal against the bearish options flow.
Tuesday's print will test whether EXE's operational story — specifically well productivity trends and the production outlook for the back half of 2026 — can close the gap between an $88 stock and a $124 consensus target, or whether the options market's defensive posture proves the more accurate read on what's inside the release.
See the live data behind this article on ORTEX.
Open EXE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
